(Q51419778)

English

Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.

scientific article published on 24 August 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

activated carbon

1 reference

based on heuristic

inferred from title

author name string

J F Tack

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

P B Miner

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

L Fischer

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

M S Harris

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

language of work or name

0 references

publication date

24 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

34

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

8

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

868-877

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

Functional gastrointestinal disorders and mast cells: implications for therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

Serotonergic modulating drugs for functional gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

Stool form scale as a useful guide to intestinal transit time

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

The validity of the Hospital Anxiety and Depression Scale. An updated literature review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

Evolution of clinical trials for irritable bowel syndrome: issues in end points and study design

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04818.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2011.04818.X

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21883322

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51419778&oldid=1572445194"